Published in Gut on February 05, 2008
Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions. Nat Rev Gastroenterol Hepatol (2010) 2.23
Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth (2011) 1.95
Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol (2011) 1.89
The pharmacological challenge to tame the transient receptor potential vanilloid-1 (TRPV1) nocisensor. Br J Pharmacol (2008) 1.48
Transient receptor potential (TRP) channels: a clinical perspective. Br J Pharmacol (2014) 1.25
Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol Ther (2011) 1.24
Plasticity of enteric nerve functions in the inflamed and postinflamed gut. Neurogastroenterol Motil (2009) 1.21
Visceral pain: the neurophysiological mechanism. Handb Exp Pharmacol (2009) 1.21
Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol (2013) 1.20
Are rice and spicy diet good for functional gastrointestinal disorders? J Neurogastroenterol Motil (2010) 1.18
Peripheral and central P2X receptor contributions to colon mechanosensitivity and hypersensitivity in the mouse. Gastroenterology (2009) 1.17
The immune system in irritable bowel syndrome. J Neurogastroenterol Motil (2011) 1.16
Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans. Prostaglandins Leukot Essent Fatty Acids (2012) 1.09
TRP channels in neurogastroenterology: opportunities for therapeutic intervention. Br J Pharmacol (2011) 1.07
An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome. J Neurogastroenterol Motil (2012) 1.07
Gastrointestinal eosinophils in health, disease and functional disorders. Nat Rev Gastroenterol Hepatol (2010) 1.06
Extrinsic primary afferent signalling in the gut. Nat Rev Gastroenterol Hepatol (2013) 1.03
Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver (2015) 1.03
Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol (2014) 1.03
Visceral pain: the ins and outs, the ups and downs. Curr Opin Support Palliat Care (2012) 1.02
Fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAPs) and nonallergic food intolerance: FODMAPs or food chemicals? Therap Adv Gastroenterol (2012) 1.01
Acupuncture Alleviates Colorectal Hypersensitivity and Correlates with the Regulatory Mechanism of TrpV1 and p-ERK. Evid Based Complement Alternat Med (2012) 1.01
Angiotensin II type 2 receptor (AT2 R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons. Eur J Pain (2012) 1.00
Effect of red pepper on symptoms of irritable bowel syndrome: preliminary study. Dig Dis Sci (2011) 0.95
TRPM8 activation attenuates inflammatory responses in mouse models of colitis. Proc Natl Acad Sci U S A (2013) 0.94
TRPV1: a new target for treatment of visceral pain in IBS? Gut (2008) 0.93
The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology. BMC Res Notes (2010) 0.89
Epigenetic regulation of genes that modulate chronic stress-induced visceral pain in the peripheral nervous system. Gastroenterology (2014) 0.88
Probiotics and irritable bowel syndrome. World J Gastroenterol (2013) 0.88
Attenuation of TRPV1 and TRPV4 Expression and Function in Mouse Inflammatory Pain Models Using Electroacupuncture. Evid Based Complement Alternat Med (2012) 0.88
Sensory and sympathetic nerve fibers undergo sprouting and neuroma formation in the painful arthritic joint of geriatric mice. Arthritis Res Ther (2012) 0.87
New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view. Pharmaceuticals (Basel) (2011) 0.87
Combined genetic and pharmacological inhibition of TRPV1 and P2X3 attenuates colorectal hypersensitivity and afferent sensitization. Am J Physiol Gastrointest Liver Physiol (2013) 0.86
The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol (2015) 0.86
ThermoTRPs and Pain. Neuroscientist (2015) 0.86
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Neuroanatomy of lower gastrointestinal pain disorders. World J Gastroenterol (2014) 0.85
Alternative targets within the endocannabinoid system for future treatment of gastrointestinal diseases. Can J Gastroenterol (2011) 0.85
Visceral analgesics: drugs with a great potential in functional disorders? Curr Opin Pharmacol (2008) 0.85
Acute colonic inflammation triggers detrusor instability via activation of TRPV1 receptors in a rat model of pelvic organ cross-sensitization. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
TRP channels in the digestive system. Curr Pharm Biotechnol (2011) 0.83
Correlation between anxiety-depression status and cytokines in diarrhea-predominant irritable bowel syndrome. Exp Ther Med (2013) 0.83
Role of the transient receptor potential vanilloid 1 in inflammation and sepsis. J Inflamm Res (2011) 0.82
Increased levels of SV2A botulinum neurotoxin receptor in clinical sensory disorders and functional effects of botulinum toxins A and E in cultured human sensory neurons. J Pain Res (2011) 0.82
TRPV1-expressing sensory fibres and IBS: links with immune function. Gut (2009) 0.82
Role of negative affects in pathophysiology and clinical expression of irritable bowel syndrome. World J Gastroenterol (2014) 0.81
Palmitoylethanolamide normalizes intestinal motility in a model of post-inflammatory accelerated transit: involvement of CB₁ receptors and TRPV1 channels. Br J Pharmacol (2014) 0.81
Shugan-decoction relieves visceral hyperalgesia and reduces TRPV1 and SP colon expression. World J Gastroenterol (2013) 0.81
Ageing and gastrointestinal sensory function: altered colonic mechanosensory and chemosensory function in the aged mouse. J Physiol (2016) 0.81
Mast Cell-Mediated Mechanisms of Nociception. Int J Mol Sci (2015) 0.80
Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia. J Physiol (2011) 0.80
Vaginal hypersensitivity and hypothalamic-pituitary-adrenal axis dysfunction as a result of neonatal maternal separation in female mice. Neuroscience (2014) 0.80
Association Between SLC6A4 Serotonin Transporter Gene Lainked Polymorphic Region and ADRA2A -1291C>G and Irritable Bowel Syndrome in Korea. J Neurogastroenterol Motil (2014) 0.80
Substance P, obesity, and gut inflammation. Curr Opin Endocrinol Diabetes Obes (2009) 0.80
Pharmacology of inflammatory pain: local alteration in receptors and mediators. Dig Dis (2010) 0.80
Roads Less Traveled: Sexual Dimorphism and Mast Cell Contributions to Migraine Pathology. Front Immunol (2016) 0.79
The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments. J Neurogastroenterol Motil (2016) 0.79
Alterations in serotonin, transient receptor potential channels and protease-activated receptors in rats with irritable bowel syndrome attenuated by Shugan decoction. World J Gastroenterol (2015) 0.79
TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitis. Mol Med (2013) 0.79
Upregulation of the transient receptor potential ankyrin 1 ion channel in the inflamed human and mouse colon and its protective roles. PLoS One (2014) 0.79
IBS and IBD - separate entities or on a spectrum? Nat Rev Gastroenterol Hepatol (2016) 0.79
Inflammation in irritable bowel syndrome: Myth or new treatment target? World J Gastroenterol (2016) 0.79
Gut pain & visceral hypersensitivity. Br J Pain (2013) 0.78
BDNF contributes to IBS-like colonic hypersensitivity via activating the enteroglia-nerve unit. Sci Rep (2016) 0.78
Decreased miR-199 augments visceral pain in patients with IBS through translational upregulation of TRPV1. Gut (2015) 0.78
TRP channel functions in the gastrointestinal tract. Semin Immunopathol (2015) 0.77
Nerve growth factor and diarrhea-predominant irritable bowel syndrome (IBS-D): a potential therapeutic target? J Zhejiang Univ Sci B (2016) 0.77
Irritable bowel syndrome: new insights into symptom mechanisms and advances in treatment. F1000Res (2016) 0.77
Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection. Medicine (Baltimore) (2016) 0.77
P2Y1, P2Y2, and TRPV1 Receptors Are Increased in Diarrhea-Predominant Irritable Bowel Syndrome and P2Y2 Correlates with Abdominal Pain. Dig Dis Sci (2016) 0.76
Effects of Chili Treatment on Gastrointestinal and Rectal Sensation in Diarrhea-predominant Irritable Bowel Syndrome: A Randomized, Double-blinded, Crossover Study. J Neurogastroenterol Motil (2014) 0.76
Identifying the Ion Channels Responsible for Signaling Gastro-Intestinal Based Pain. Pharmaceuticals (Basel) (2010) 0.76
Translating the human genome to manage pediatric postoperative pain. J Pediatr Surg Nurs (2015) 0.76
CT-guided injection of a TRPV1 agonist around dorsal root ganglia decreases pain transmission in swine. Sci Transl Med (2015) 0.76
The mucosal immune system: master regulator of bidirectional gut-brain communications. Nat Rev Gastroenterol Hepatol (2017) 0.75
New Pathways, New Targets: Visceral Hypersensitivity Pathogenesis in Irritable Bowel Syndrome. Clin Transl Gastroenterol (2016) 0.75
The Role of Mast Cells in Irritable Bowel Syndrome. Gastroenterol Res Pract (2016) 0.75
Neonatal maternal separation increases susceptibility to experimental colitis and acute stress exposure in male mice. IBRO Rep (2016) 0.75
Diagnosis and management of functional symptoms in inflammatory bowel disease in remission. World J Gastrointest Pharmacol Ther (2016) 0.75
Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform. J Vis Exp (2016) 0.75
TRPA1 in the spinal dorsal horn is involved in post-inflammatory visceral hypersensitivity: in vivo study using TNBS-treated rat model. J Pain Res (2016) 0.75
2020 Foresight: Envisioning Therapeutic Innovations for Pain. Drug Discov Today Ther Strateg (2009) 0.75
Pharmacodynamics of TRPV1 agonists in a bioassay using human PC-3 cells. ScientificWorldJournal (2014) 0.75
Red pepper: an aid for gut functional diseases with pain? Ann Gastroenterol (2013) 0.75
Mechanistic understanding of the effects of probiotics in the modulation of abdominal pain: one study at a time. J Physiol (2015) 0.75
Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients! World J Gastroenterol (2017) 0.75
Protective effect of huoxiang zhengqi oral liquid on intestinal mucosal mechanical barrier of rats with postinfectious irritable bowel syndrome induced by acetic Acid. Evid Based Complement Alternat Med (2014) 0.75
Saccharomyces boulardii CNCM I-745 supplementation reduces gastrointestinal dysfunction in an animal model of IBS. PLoS One (2017) 0.75
Cross-sensitization mechanisms between colon and bladder via transient receptor potential A1 stimulation in rats. Int Urogynecol J (2014) 0.75
Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal. J Neurogastroenterol Motil (2017) 0.75
Regulation of transient receptor potential cation channel subfamily V1 protein synthesis by the phosphoinositide 3-kinase/Akt pathway in colonic hypersensitivity. Exp Neurol (2017) 0.75
Post-Infectious Irritable Bowel Syndrome. Curr Gastroenterol Rep (2017) 0.75
Pharmacological evaluation of NSAID-induced gastropathy as a "Translatable" model of referred visceral hypersensitivity. World J Gastroenterol (2017) 0.75
The hospital anxiety and depression scale. Acta Psychiatr Scand (1983) 121.58
An inventory for measuring depression. Arch Gen Psychiatry (1961) 84.61
The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature (1997) 30.59
The short-form McGill Pain Questionnaire. Pain (1987) 14.40
Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev (1999) 7.20
Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology (2005) 5.75
Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology (2002) 5.50
Irritable bowel syndrome in the general population. BMJ (1992) 5.26
p38 MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron (2002) 4.27
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology (2004) 4.05
Induction of vanilloid receptor channel activity by protein kinase C. Nature (2001) 3.95
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. Gastroenterology (1992) 2.66
Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology (2007) 2.63
Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology (2003) 2.39
Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology (2006) 2.28
Symptom complaints and health care seeking behavior in subjects with bowel dysfunction. Gastroenterology (1984) 2.24
Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil (2000) 2.16
Postinfectious irritable bowel syndrome. Gastroenterology (2003) 2.12
Mechanisms of hypersensitivity in IBS and functional disorders. Neurogastroenterol Motil (2007) 1.98
Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol (2003) 1.92
Regulation of Ca2+-dependent desensitization in the vanilloid receptor TRPV1 by calcineurin and cAMP-dependent protein kinase. J Biol Chem (2005) 1.86
Vanilloid receptor 1 antagonists attenuate disease severity in dextran sulphate sodium-induced colitis in mice. Neurogastroenterol Motil (2004) 1.83
Impact of irritable bowel syndrome on quality of life. Dig Dis Sci (1996) 1.81
Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet (2001) 1.79
Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet (2003) 1.74
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology (2006) 1.54
Colonic mucosal abnormalities associated with oral sodium phosphate solution. Gastrointest Endosc (1996) 1.53
Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures. Exp Dermatol (2004) 1.52
Role of infection in irritable bowel syndrome. J Gastroenterol (2007) 1.50
TRPV1 function in mouse colon sensory neurons is enhanced by metabotropic 5-hydroxytryptamine receptor activation. J Neurosci (2004) 1.34
Changes in the rectal mucosa induced by hypertonic enemas. Dis Colon Rectum (1978) 1.24
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
Vanilloid receptor-1 containing primary sensory neurones mediate dextran sulphate sodium induced colitis in rats. Gut (2003) 1.15
Visceral perception: inflammatory and non-inflammatory mediators. Gut (2002) 1.12
Physical and psychological co-morbidity in irritable bowel syndrome: a matched cohort study using the General Practice Research Database. Aliment Pharmacol Ther (2006) 1.09
Colorectal inflammation and increased cell proliferation associated with oral sodium phosphate bowel preparation solution. Hum Pathol (1998) 1.00
Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease. Gut (2000) 0.99
Novel capsaicin (VR1) and purinergic (P2X3) receptors in Hirschsprung's intestine. J Pediatr Surg (2001) 0.93
Study of visceral hypersensitivity in irritable bowel syndrome. Chin J Dig Dis (2004) 0.88
Histopathological alterations in irritable bowel syndrome. Mod Pathol (2006) 0.87
Psychological aspects of irritable bowel syndrome: comparisons with inflammatory bowel disease and nonpatient controls. Behav Res Ther (1993) 0.87
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature (1995) 10.36
MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell (1998) 8.73
Inhibition of NF-kappa B by sodium salicylate and aspirin. Science (1994) 7.60
Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300. Mol Cell (1998) 7.03
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
NF-kappaB and the immune response. Oncogene (2006) 5.62
The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell (1997) 4.99
NICE guidance on CardioQ(TM) oesophageal Doppler monitoring. Anaesthesia (2011) 4.63
Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol (1996) 4.56
Signal transduction through NF-kappa B. Immunol Today (1998) 4.54
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature (1991) 4.27
Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex. Science (2000) 4.04
Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care (1998) 3.99
I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell (1995) 3.95
Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (1991) 3.76
Structure of NF-kappa B p50 homodimer bound to a kappa B site. Nature (1995) 3.59
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev (1992) 3.47
High-resolution manometry predicts the success of oesophageal bolus transport and identifies clinically important abnormalities not detected by conventional manometry. Neurogastroenterol Motil (2004) 3.44
TRPV3 is a temperature-sensitive vanilloid receptor-like protein. Nature (2002) 3.23
Concern Randomised controlled trial of cardioprotective diet in patients with recent acute myocardial infarction: results of one year follow up. BMJ (1992) 3.14
Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J Clin Invest (2001) 3.04
Quantitative quality control in microarray image processing and data acquisition. Nucleic Acids Res (2001) 2.91
Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study. Diabetes (1997) 2.76
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther (2013) 2.74
Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther (2009) 2.73
Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clin Pharmacol Ther (2009) 2.60
Direct demonstration of P-selectin- and VCAM-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein E-deficient mice. Circ Res (1999) 2.60
NF-kappa B and rel proteins in innate immunity. Adv Immunol (1995) 2.53
Coeliac disease-associated risk variants in TNFAIP3 and REL implicate altered NF-kappaB signalling. Gut (2009) 2.50
Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating. Histochemistry (1983) 2.35
Mechanisms of mutations inhibiting fusion and infection by Semliki Forest virus. J Cell Biol (1996) 2.25
Spinal nerve root repair and reimplantation of avulsed ventral roots into the spinal cord after brachial plexus injury. J Neurosurg (2000) 2.22
Intra-articular bupivacaine: potentially chondrotoxic? Br J Anaesth (2009) 2.20
The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50. EMBO J (1992) 2.19
ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev (1999) 2.17
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A (2007) 2.07
Microsatellites for linkage analysis of genetic traits. Trends Genet (1992) 2.05
Substrate nucleotide-determined non-templated addition of adenine by Taq DNA polymerase: implications for PCR-based genotyping and cloning. Biotechniques (1996) 2.02
Inhaled nitric oxide in patients with normal and increased pulmonary vascular resistance after cardiac surgery. Br J Anaesth (1994) 2.01
A glycine-rich region in NF-kappaB p105 functions as a processing signal for the generation of the p50 subunit. Mol Cell Biol (1996) 2.01
EFNS guidelines on neuropathic pain assessment. Eur J Neurol (2004) 1.96
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Gut (2003) 1.95
A case for a combined mother and child card. Indian Pediatr (1987) 1.92
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity (2000) 1.91
Role of unphosphorylated, newly synthesized I kappa B beta in persistent activation of NF-kappa B. Mol Cell Biol (1996) 1.91
Two distinct Raf domains mediate interaction with Ras. J Biol Chem (1995) 1.88
Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol (1997) 1.88
Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol (2001) 1.87
Anaerobic acidogenesis of wastewater sludge. J Water Pollut Control Fed (1975) 1.87
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity. J Urol (2005) 1.86
Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis. Br J Urol (1997) 1.85
A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34. Nat Genet (1994) 1.81
Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice. Heterogeneity of hormone expression. Am J Pathol (1990) 1.80
Reactive oxygen species level in follicular fluid--embryo quality marker in IVF? Hum Reprod (2006) 1.80
Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet (2001) 1.79
Additional microsatellite markers for mouse genome mapping. Mamm Genome (1991) 1.79
Familiality of quantitative metabolic traits in Finnish families with non-insulin-dependent diabetes mellitus. Finland-United States Investigation of NIDDM Genetics (FUSION) Study investigators. Hum Hered (1999) 1.76
Resuturing following penetrating keratoplasty: a retrospective analysis. Br J Ophthalmol (2008) 1.75
Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75
Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet (2003) 1.74
Ligation of CD40 stimulates the induction of nitric-oxide synthase in microglial cells. J Biol Chem (2001) 1.71
Interleukin 6 secreted from adipose stromal cells promotes migration and invasion of breast cancer cells. Oncogene (2009) 1.69
A novel DNA recognition mode by the NF-kappa B p65 homodimer. Nat Struct Biol (1998) 1.68
Calmodulin activates intersubunit electron transfer in the neuronal nitric-oxide synthase dimer. J Biol Chem (2001) 1.68
Cysticercosis causing single, small CT lesions in Indian patients with seizures. Lancet (1989) 1.66
Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. Br J Haematol (2005) 1.65
Socio-cultural factors affecting breast feeding and other infant feeding practices in an urban community. Indian Pediatr (1976) 1.64
EFNS guidelines on neuropathic pain assessment: revised 2009. Eur J Neurol (2010) 1.63
The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60
Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J Biol Chem (2000) 1.57
Prevalence of diabetes and impaired fasting glucose in a selected population with special reference to influence of family history and anthropometric measurements--the Kolkata policeman study. J Assoc Physicians India (2008) 1.56
The solution structure of the Raf-1 cysteine-rich domain: a novel ras and phospholipid binding site. Proc Natl Acad Sci U S A (1996) 1.54
Phosphorylation of serine 51 in initiation factor 2 alpha (eIF2 alpha) promotes complex formation between eIF2 alpha(P) and eIF2B and causes inhibition in the guanine nucleotide exchange activity of eIF2B. Biochemistry (2000) 1.54
The Finland-United States investigation of non-insulin-dependent diabetes mellitus genetics (FUSION) study. II. An autosomal genome scan for diabetes-related quantitative-trait loci. Am J Hum Genet (2000) 1.53
Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurosurg Psychiatry (1991) 1.53
A ferromagnet in a continuously tunable random field. Nature (2007) 1.52
Goiter prevalence and iodine nutritional status of school children in a sub-Himalayan Tarai region of eastern Uttar Pradesh. Indian Pediatr (2008) 1.52
Haplotyping in pedigrees via a genetic algorithm. Hum Hered (2000) 1.51
Current-induced polarization and the spin Hall effect at room temperature. Phys Rev Lett (2006) 1.50
Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians. Int J Obes (Lond) (2006) 1.49
cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium. J Cell Physiol (1994) 1.47
Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature (1977) 1.47
Role of the guanosine triphosphatase Rac2 in T helper 1 cell differentiation. Science (2000) 1.46
Identification and characterization of a novel human vanilloid receptor-like protein, VRL-2. Physiol Genomics (2001) 1.46
bFGF is the putative natural growth factor for human melanocytes. In Vitro Cell Dev Biol (1987) 1.46
Reduced long-term survival following major peptic ulcer haemorrhage. Br J Surg (1997) 1.46
Structure of salicylaldehyde thiosemicarbazone. Acta Crystallogr C (1988) 1.44
Keratitis, ichthyosis, deafness (KID) syndrome--the first report from India. Clin Exp Dermatol (1993) 1.43
The role of soda lime during administration of inhaled nitric oxide. Br J Anaesth (1994) 1.43
Changing pattern of human group A rotaviruses: emergence of G12 as an important pathogen among children in eastern India. J Clin Virol (2006) 1.42
Hepatic dysfunction in childhood malaria. Arch Dis Child (1979) 1.42